The economic burden of systemic lupus erythematosus in Mexico

References

• Justiz Vaillant AA, Goyal A, Varacallo M. Systemic lupus erythematosus. In: statPearls [Internet]. Treasure Island (FL): statPearls Publishing; 2023. [updated 2023 Aug 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535405/
   Google Scholar
• Meacock R, Dale N, Harrison MJ. The humanistic and economic burden of systemic lupus erythematosus: a systematic review. Pharmacoeconomics. 2013;31(1):49–61. doi: 10.1007/s40273-012-0007-4.
   PubMed Web of Science ®Google Scholar
• Health at a Glance. 2023: highlights for Mexico, OECD. https://www.oecd.org/mexico/health-at-a-glance-Mexico-EN.pdf.
   Google Scholar
• Tian J, Zhang D, Yao X, et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351–356. doi: 10.1136/ard-2022-223035.
   PubMed Web of Science ®Google Scholar
• Somers EC, Marder W, Cagnoli P, et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan lupus epidemiology and surveillance program. Arthritis Rheumatol. 2014;66(2):369–378. doi: 10.1002/art.38238.
   PubMed Web of Science ®Google Scholar
• Peláez-Ballestas I, Sanin LH, Moreno-Montoya J, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl. 2011;86(0):3–8. doi: 10.3899/jrheum.100951.
   PubMedGoogle Scholar
• Mendoza-Pinto C, Etchegaray-Morales I, Garcia-Carrasco M, et al. Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: results from a nationwide health registry. Lupus. 2022;31(3):382–391. doi: 10.1177/09612033221078228.
   PubMed Web of Science ®Google Scholar
• Olesińska M, Saletra A. Quality of life in systemic lupus erythematosus and its measurement. Reumatologia. 2018;56(1):45–54. doi: 10.5114/reum.2018.74750.
   PubMedGoogle Scholar
• Etchegaray-Morales I, Méndez-Martínez S, Jiménez-Hernández C, et al. Factors associated with health-related quality of life in Mexican lupus patients using the LupusQol. PLoS One. 2017;12(1):e0170209. doi: 10.1371/journal.pone.0170209.
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Feletar M, Bruce IN, et al. Prolonged remission in systemic lupus erythematosus. J Rheumatol. 2005;32(8):1467–1472.
   PubMed Web of Science ®Google Scholar
• Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017;28(1):4–12. doi: 10.31138/mjr.28.1.4.
   PubMedGoogle Scholar
• Bell CF, Huang SP, Cyhaniuk A, et al. The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States. Lupus. 2023;32(2):301–309. doi: 10.1177/09612033221146093.
   PubMed Web of Science ®Google Scholar
• Pego-Reigosa JM, Nicholson L, Pooley N, et al. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology. 2021;60(1):60–72. doi: 10.1093/rheumatology/keaa478.
   PubMed Web of Science ®Google Scholar
• Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144–150. doi: 10.1097/BOR.0000000000000480.
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Lewandowski LB, Hu J, et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017;76(12):2009–2016. doi: 10.1136/annrheumdis-2017-211663.
   PubMed Web of Science ®Google Scholar
• Tamirou F, Arnaud L, Talarico R, et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2):e000793. doi: 10.1136/rmdopen-2018-000793.
   PubMedGoogle Scholar
• Arnaud L, Tektonidou MG. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology. 2020;59(Suppl5):v29–v38. doi: 10.1093/rheumatology/keaa382.
   PubMedGoogle Scholar
• Prada SI, Pérez AM, Nieto-Aristizábal I, et al. Increase in direct costs for health systems due to lupus nephritis: the case of Colombia. Einstein. 2022;20:eAO6553. doi: 10.31744/einstein_journal/2022AO6553.
   PubMed Web of Science ®Google Scholar
• Fatoye F, Gebrye T, Svenson LW. Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada. PLoS One. 2021;16(5):e0251409. doi: 10.1371/journal.pone.0251409.
   PubMed Web of Science ®Google Scholar
• Lin DH, Murimi-Worstell IB, Kan H, et al. Health care utilization and costs of systemic lupus erythematosus in the United States: a systematic review. Lupus. 2022;31(7):773–807. doi: 10.1177/09612033221088209.
   PubMed Web of Science ®Google Scholar
• Schwarting A, Friedel H, Garal-Pantaler E, et al. The burden of systemic lupus erythematosus in Germany: incidence, prevalence, and healthcare resource utilization. Rheumatol Ther. 2021;8(1):375–393. doi: 10.1007/s40744-021-00277-0.
   PubMed Web of Science ®Google Scholar
• Durcan L, O'Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332–2343. doi: 10.1016/S0140-6736(19)30237-5.
   PubMed Web of Science ®Google Scholar
• Isenberg DA, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the British isles lupus assessment group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005;44(7):902–906. doi: 10.1093/rheumatology/keh624.
   PubMed Web of Science ®Google Scholar
• The World Bank. Population ages 15-64, total – Mexico. 2023. Available from https://data.worldbank.org/indicator/SP.POP.1564.TO?locations=MX.
   Google Scholar
• The World Bank. Population ages 65 and above, total – Mexico. 2023. Available from; https://data.worldbank.org/indicator/SP.POP.65UP.TO?locations=MX.
   Google Scholar
• Castro-Villarreal S, Beltran-Ostos A, Valencia CF. Estimation of prevalence and incremental costs of systemic lupus erythematosus in a Middle-income country using machine learning on administrative health data. Value Health Reg Issues. 2021;26:98–104. doi: 10.1016/j.vhri.2021.04.005.
   PubMedGoogle Scholar
• Nikolopoulos DS, Kostopoulou M, Pieta A, et al. Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease. Lupus Sci Med. 2020;7(1):e000394. doi: 10.1136/lupus-2020-000394.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li W, Zhang P, et al. Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis—a case-control study. Arthritis Res Ther. 2022;24(1):5. doi: 10.1186/s13075-021-02692-8.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS)–explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–250. doi: 10.1016/j.jval.2013.02.002.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Briggs AH, Siebert U, et al. Modeling good research practices–overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Med Decis Making. 2012;32(5):667–677. doi: 10.1177/0272989X12454577.
   PubMed Web of Science ®Google Scholar
• Stevens B, Pezzullo L, Verdian L, et al. The economic burden of hypertension, heart failure, myocardial infarction, and atrial fibrillation in Mexico. Arch Cardiol Mex. 2018;88(3):241–244. doi: 10.1016/j.acmx.2018.03.004.
   PubMedGoogle Scholar
• Catoggio LJ, Soriano ER, Imamura PM, et al. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup? Lupus. 2015;24(8):788–795. doi: 10.1177/0961203314563134.
   PubMed Web of Science ®Google Scholar
• Hernández Cruz B, Alonso F, Calvo Alén J, et al. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry). Lupus. 2020;29(1):27–36. doi: 10.1177/0961203319889667.
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol. 2016;68(6):1432–1441. doi: 10.1002/art.39594.
   PubMed Web of Science ®Google Scholar
• Barile LA, Jara LJ, Medina-Rodriguez F, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Lupus. 1997;6(5):445–448. doi: 10.1177/096120339700600506.
   PubMed Web of Science ®Google Scholar
• Hammond ER, Desta B, Near AM, et al. Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015. Lupus Sci Med. 2021;8(1):e000504. doi: 10.1136/lupus-2021-000504.
   PubMed Web of Science ®Google Scholar
• Ko T, Koelmeyer R, Li N, et al. Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Semin Arthritis Rheum. 2022;57:152099. doi: 10.1016/j.semarthrit.2022.152099.
   PubMed Web of Science ®Google Scholar
• The word bank, gender data portal, Mexico. 2023. Available from: https://genderdata.worldbank.org/countries/mexico/#:∼:text=In%20Mexico%2C%20the%20labor%20force,older%20that%20is%20economically%20active.
   Google Scholar
• Drenkard C, Bao G, Dennis G, et al. Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States. Arthritis Care Res (Hoboken). 2014;66(6):878–887. doi: 10.1002/acr.22245.
   PubMed Web of Science ®Google Scholar
• Utset TO, Baskaran A, Segal BM, et al. Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus. Lupus Sci Med. 2015;2(1):e000058–e000058. doi: 10.1136/lupus-2014-000058.
   PubMedGoogle Scholar
• The World Bank. GDP per capita (constant LCU) - Mexico. 2023. Available from; https://data.worldbank.org/indicator/NY.GDP.PCAP.KN?locations=MX.
   Google Scholar
• Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: an update for clinicians. Ther Adv Chronic Dis. 2010;1(4):163–175. doi: 10.1177/2040622310380100.
   PubMedGoogle Scholar
• Karim MY, Alba P, Cuadrado MJ, et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology. 2002;41(8):876–882. doi: 10.1093/rheumatology/41.8.876.
   PubMed Web of Science ®Google Scholar
• Porta S, Danza A, Arias Saavedra M, et al. Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues. J Clin Med. 2020;9(9):2709. doi: 10.3390/jcm9092709.
   PubMed Web of Science ®Google Scholar
• Kernder A, Richter JG, Fischer-Betz R, et al. Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort. Lupus. 2021;30(3):431–438. doi: 10.1177/0961203320983445.
   PubMed Web of Science ®Google Scholar
• Badsha H, Teh CL, Kong KO, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum. 2004;33(6):414–421. doi: 10.1016/j.semarthrit.2003.09.006.
   PubMed Web of Science ®Google Scholar
• Bhatt V, Koneru K, Zanwar A, et al. A case of acute breathlessness in systemic lupus erythematosus: a devastating complication. J Clin of Diagn Res. 2022;16(6):OD14–OD16. doi: 10.7860/JCDR/2022/55748/16509.
   Web of Science ®Google Scholar
• Zhu TY, Tam LS, Lee VW, et al. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum. 2009;61(9):1159–1167. doi: 10.1002/art.24725.
   PubMedGoogle Scholar
• Al Sawah S, Daly RP, Foster SA, et al. The caregiver burden in lupus: findings from UNVEIL, a national online lupus survey in the United States. Lupus. 2017;26(1):54–61. doi: 10.1177/0961203316651743.
   PubMed Web of Science ®Google Scholar
• Jönsen A, Hjalte F, Willim M, et al. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts. Semin Arthritis Rheum. 2016;45(6):684–690. doi: 10.1016/j.semarthrit.2015.11.013.
   PubMed Web of Science ®Google Scholar
• Macejova Z, Madarasova Geckova A, Husarova D, et al. Living with systematic lupus erythematosus: a profile of young female patients. Int J Environ Res Public Health. 2020;17(4):1315. doi: 10.3390/ijerph17041315.
   PubMed Web of Science ®Google Scholar
• Segura BT, Bernstein BS, McDonnell T, et al. Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort. Rheumatology. 2020;59(3):698–698. doi: 10.1093/rheumatology/kez516.
   PubMed Web of Science ®Google Scholar
• Murimi-Worstell IB, Lin DH, Nab H, et al. Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open. 2020;10(5):e031850. doi: 10.1136/bmjopen-2019-031850.
   PubMed Web of Science ®Google Scholar
• Barber MRW, Hanly JG, Su L, et al. Economic evaluation of damage accrual in an international systemic lupus erythematosus inception cohort using a multistate model approach. Arthritis Care Res. 2020;72(12):1800–1808. doi: 10.1002/acr.24092.
   Web of Science ®Google Scholar